Indaptus Therapeutics (INDP) Earnings Date, Estimates & Call Transcripts

$2.31
-0.09 (-3.75%)
(As of 05/17/2024 ET)

Earnings Summary

Upcoming
Earnings Date
Aug. 12Estimated
Actual EPS
(Mar. 13)
-$0.47 Beat By $0.07
Consensus EPS
(Mar. 13)
-$0.54
Skip Charts & View Estimated and Actual Earnings Data

INDP Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

INDP Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Indaptus Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241($0.57)($0.57)($0.57)
Q2 20241($0.60)($0.60)($0.60)
Q3 20241($0.42)($0.42)($0.42)
Q4 20241($0.34)($0.34)($0.34)
FY 20244($1.93)($1.93)($1.93)
Q1 20251($0.38)($0.38)($0.38)
Q2 20251($0.37)($0.37)($0.37)
Q3 20251($0.35)($0.35)($0.35)
Q4 20251($0.35)($0.35)($0.35)
FY 20254($1.45)($1.45)($1.45)

INDP Earnings Date and Information

Indaptus Therapeutics last posted its quarterly earnings data on March 13th, 2024. The reported ($0.47) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.54) by $0.07. Indaptus Therapeutics has generated ($1.78) earnings per share over the last year (($1.78) diluted earnings per share). Earnings for Indaptus Therapeutics are expected to grow in the coming year, from ($1.83) to ($1.44) per share. Indaptus Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 12th, 2024 based off prior year's report dates.

Indaptus Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/12/2024
Estimated)
------- 
3/13/2024Q4 2023($0.54)($0.47)+$0.07($0.47)--
11/6/2023Q3 2023($0.55)($0.47)+$0.08($0.47)--
8/14/2023Q2 2023($0.58)($0.39)+$0.19($0.39)--
5/11/2023Q1 2023($0.59)($0.51)+$0.08($0.51)--
3/17/2023Q4 2022($0.52)($0.44)+$0.08($0.44)--
11/10/2022Q3 2022($0.47)($0.42)+$0.05($0.42)--
8/8/2022Q2 2022($0.43)($0.46)($0.03)($0.46)--
5/12/2022Q1 2022($0.39)($0.41)($0.02)($0.41)--
11/15/2021Q3 2021($1.64)($0.81)+$0.83($0.81)--
8/16/2021Q2 2021-($5.53)($5.53)($5.53)--

Indaptus Therapeutics Earnings - Frequently Asked Questions

When is Indaptus Therapeutics's earnings date?

Indaptus Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 12th, 2024 based off last year's report dates. Learn more on INDP's earnings history.

Did Indaptus Therapeutics beat their earnings estimates last quarter?

In the previous quarter, Indaptus Therapeutics (NASDAQ:INDP) reported ($0.47) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.54) by $0.07. Learn more on analysts' earnings estimate vs. INDP's actual earnings.

How much profit does Indaptus Therapeutics generate each year?

Indaptus Therapeutics (NASDAQ:INDP) has a recorded net income of -$15.42 million. INDP has generated -$1.78 earnings per share over the last four quarters.

What is Indaptus Therapeutics's EPS forecast for next year?

Indaptus Therapeutics's earnings are expected to grow from ($1.83) per share to ($1.44) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:INDP) was last updated on 5/19/2024 by MarketBeat.com Staff

From Our Partners